Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

AstraZeneca, Columbia To Study Neurogenesis

by Lisa M. Jarvis
October 20, 2008 | A version of this story appeared in Volume 86, Issue 42

AstraZeneca and Columbia University Medical Center have inked a research pact centered on neurology. The partners will study how neurogenesis, or the creation of neuronal cells, in adult brains could lead to new routes for treating depression and anxiety. Scientists only recently discovered that neurogenesis can occur in the adult brain; the hope is to tap into the power of those new neurons to stimulate the hippocampus and, ultimately, treat neurological disorders. In June, AstraZeneca and Columbia established a research collaboration focused on metabolic diseases.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.